IMMUNEERING CORP - CLASS A (IMRX) Stock Analyst Earnings Estimates
NASDAQ:IMRX - Nasdaq - US45254E1073 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.31M 20.31% | 2.08M -9.96% | 320K -84.62% | -100.00% | 25.551M | 57.582M 125.36% | 86.52M 50.26% | 200.08M 131.25% | 323.55M 61.71% | 450.09M 39.11% | ||||
| EBITDA YoY % growth | -17.06M -171.66% | -33.84M -98.36% | -51.46M -52.07% | -59.355M -12.83% | -66.372M -14.32% | -79.028M -19.07% | -89.405M -13.13% | -133.518M -49.34% | -145.248M -8.79% | -149.532M -2.95% | -102M 31.79% | 2.448M 102.40% | 212.87M 8,595.67% | |
| EBIT YoY % growth | -17.08M -171.11% | -33.89M -98.42% | -51.74M -52.67% | -58.458M -12.90% | -65.761M -12.58% | -86.347M -31.30% | -105.094M -21.71% | -104.773M 0.31% | -91.434M 12.73% | -128.024M -40.02% | -51.926M 59.44% | 32.802M 163.17% | 165.24M 403.75% | |
| Operating Margin | -739.39% | -1,629.33% | -16,168.75% | N/A | N/A | N/A | N/A | -410.05% | -158.79% | -147.97% | -25.95% | 10.14% | 36.71% | |
| EPS YoY % growth | N/A | N/A | -1.92 43.61% | -1.88 1.56% | -1.95 -3.44% | -1.63 16.76% | -1.98 -21.54% | -1.63 17.61% | -1.29 21.13% | -1.05 18.25% | -0.11 89.32% | 0.62 650.00% | 1.37 122.31% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 3.02% | -0.50 -2.00% | -0.39 17.53% | -0.38 22.29% | -0.33 34.26% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.934M -16.14% | -25.092M -63.72% | -26.112M -75.09% | -27.642M -53.83% | -26.017M -37.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.49 -13.95% | -0.56 | 0.07 | 12.88% |
| Q2 2024 Q2Q % growth | -0.47 -9.30% | -0.54 | 0.07 | 12.35% |
| Q1 2024 Q2Q % growth | -0.49 3.92% | -0.51 | 0.02 | 4.47% |
| Q4 2023 Q2Q % growth | -0.52 -4.00% | -0.48 | -0.04 | -9.09% |
| Q3 2023 Q2Q % growth | -0.43 12.24% | -0.50 | 0.07 | 14.62% |
| Q2 2023 Q2Q % growth | -0.43 2.27% | -0.54 | 0.11 | 20.08% |
| Q1 2023 Q2Q % growth | -0.51 -4.08% | -0.57 | 0.06 | 10.71% |
| Q4 2022 Q2Q % growth | -0.50 -19.05% | -0.59 | 0.09 | 14.85% |
| Q3 2022 Q2Q % growth | -0.49 -4.26% | -0.50 | 0.01 | 1.63% |
| Q2 2022 Q2Q % growth | -0.44 72.67% | -0.53 | 0.09 | 17.27% |
| Q1 2022 Q2Q % growth | -0.49 | -0.46 | -0.03 | -6.75% |
| Q4 2021 Q2Q % growth | -0.42 | -0.40 | -0.02 | -5.04% |
| Q3 2021 Q2Q % growth | -0.47 | -0.58 | 0.11 | 19.16% |
| Q2 2021 Q2Q % growth | -1.61 | -1.47 | -0.14 | -9.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | 10.2K | -10.2K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 61.2K | -61.2K | -100.00% |
| Q3 2022 Q2Q % growth | 40K -91.67% | 155.377K | -115.377K | -74.26% |
| Q2 2022 Q2Q % growth | 90K -86.36% | 180.877K | -90.877K | -50.24% |
| Q1 2022 Q2Q % growth | 180K -76.00% | 234.6K | -54.6K | -23.27% |
| Q4 2021 Q2Q % growth | 190K -91.78% | 571.883K | -381.883K | -66.78% |
| Q3 2021 Q2Q % growth | 480K | 663K | -183K | -27.60% |
| Q2 2021 Q2Q % growth | 660K 37.50% | 382.5K | 277.5K | 72.55% |
| Q1 2021 Q2Q % growth | 750K 56.25% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -1.38% | -1.63% |
| Revenue | N/A | N/A | N/A | N/A |